Cargando…
Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany
BACKGROUND: In line with current guideline recommendations, patients at high cardiovascular risk are usually treated with statins for secondary as well as for primary prevention. While many studies investigated treatment goal achievement with regards to low-density lipoprotein (LDL-C) and total chol...
Autores principales: | Gitt, Anselm K., Jünger, Claus, Smolka, Wenefrieda, Bestehorn, Kurt |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2959161/ https://www.ncbi.nlm.nih.gov/pubmed/20521058 http://dx.doi.org/10.1007/s00392-010-0177-z |
Ejemplares similares
-
Lipid management in 13,000 high risk cardiovascular patients treated under daily practice conditions: LIMA Registry
por: Schaefer, Juergen R, et al.
Publicado: (2013) -
Results of the Dyslipidemia International Study (DYSIS)-Middle East: Clinical Perspective on the Prevalence and Characteristics of Lipid Abnormalities in the Setting of Chronic Statin Treatment
por: Al Sifri, Saud N., et al.
Publicado: (2014) -
Prevalence of lipid abnormalities and cholesterol target value attainment in Egyptian patients presenting with an acute coronary syndrome
por: Sobhy, Mohamed, et al.
Publicado: (2018) -
Prevalence of persistent lipid abnormalities in statin-treated patients: Belgian results of the Dyslipidaemia International Study (DYSIS)
por: Devroey, D, et al.
Publicado: (2014) -
Prevalence of Lipid Abnormalities and Cholesterol Target Value Attainment in Patients with Stable and Acute Coronary Heart Disease in the United Arab Emirates
por: Al Mahmeed, Wael, et al.
Publicado: (2019)